secwatch.observer — SEC 8-K summary
======================================

Issuer:     iRhythm Holdings, Inc. (IRTC)
CIK:        0001388658
Form:       8-K
Filed at:   2026-08-06T20:15:12+00:00
Accession:  0001388658-26-000070
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iRhythm Q2 revenue $224M (+20% YoY), raises guidance; acquires VitalConnect for $287.5M
--------------------------------------------------------------------------------

- Revenue $224.2M (+20.1% YoY); net loss $0.4M vs $14.2M loss; adjusted EBITDA $43.3M (19.3% margin).
- FY2026 revenue guidance raised to $880-890M; adjusted EBITDA margin 13-14%.
- Acquiring VitalConnect for ~$287.5M ($237.5M cash + $50M stock); expected close by end of 2026.
- Settled Baxter patent litigation with $50M payment; cross-license and 6-year covenant not to sue.
- FDA cleared third-gen algorithm; expected to cut clinician review time ~50% and save $100M over 5 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388658/000138865826000070/0001388658-26-000070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388658/000138865826000070/irtc-20260731.htm
  HTML page:      https://secwatch.observer/filing/0001388658-26-000070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer